# Adverse Events Related to Treatments Used Against Coronavirus Disease 2019

> **NCT04314817** · — · COMPLETED · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 1000 (actual)

## Conditions studied

- Coronavirus
- Iatrogenic Disease
- Acute Kidney Injury
- ARDS, Human

## Interventions

- **DRUG:** Any drug used to treat Covid-19

## Key facts

- **NCT ID:** NCT04314817
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-17
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04314817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04314817, "Adverse Events Related to Treatments Used Against Coronavirus Disease 2019". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04314817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*